AT Penlon America has introduced the Visensia Patient Index Software into the US healthcare marketplace. The Visensia Index is a patented, FDA approved, algorithmic software which automatically analyses and interprets a patient’s vital signs and then fuses the data to generate a predictive, numerical index. Visensia provides the clinician with a highly reliable patient status index based on heart rate, respiration rate, temperature, oxygen saturation and BP. When an alert is activated by Visensia it indicates a patient is moving away from a model of normality and on a trajectory towards critical instability.
For more information, visit: www.penlon.com